In particular, we found that MET up‐regulated SCRIB, leading to YAP phosphorylation and localization to the cytoplasm, and ultimately to inhibition of the growth and invasion of TAM‐ and TAX‐resistant breast cancer cells. Here, MET is linked to breast carcinoma.